Have a complex challenge with an ADC or bioconjugate?
Contact Us

Simplifying bioconjugate development and manufacture


Our full service offering for bioconjugates provides you with tailored drug intermediate manufacturing, process and analytical development, formulation development, drug substance manufacturing and drug product development and manufacturing services, all under one quality system supported by global regulatory services and writing support. Our scientists and engineers bring a decade of development experience across a broad spectrum of both platform and novel conjugation technologies. We also understand your need to pace and manage investments in the different phases of the  development cycle and offer flexible business models to help meet your specific program needs. 

Our experience spans a broad range of bioconjugation technologies, including ADCs, radio-immunoconjugates (mAb conjugated to chelating agents), vaccines (haptens conjugated to carrier proteins), PEGylation and cross-linking, antibodies conjugated to nanoparticles (TNPs) and non-cytotoxic drugs (including peptides). Our services are geared to enable the commercialization of your drug candidate and we have a successful track record of marketed bioconjugates. 

Our highly experienced regulatory affairs team has the capability to support your project at all stages of the development lifecycle from concept to commercialization. We were among the first CDMOs to support commercialization of bioconjugates. This experience allows us to advise you on developing your regulatory and submission strategies, preparing you for success.

LPB-A.04-BioconjugateServices-TheNextGenerationofPharmaceuticals

We manufacture the majority of commercial ADC therapeutics, which are approved in 60+ countries

The next generation of pharmaceuticals

Antibody-Drug Conjugates represent an innovative therapeutic application that combines the unique properties of mAbs with the potent cell killing activity of cytotoxic small molecule drugs.

Phase appropriate services


Our services and equipment are tailored appropriately to pace your investments from pre-clinical to commercialization. We collaborate closely with you to align our services with your needs. We focus on your next milestone with your ultimate goal in mind.

service
Process Definition and Sample Preparation
We have experience with a wide range of platform and novel bioconjugation technologies to support drug discovery activities. We can perform cell line construction/strain development, GMP cell banking, manufacture both your payload and linker and perform t...
service
Process Development and Optimization
We leverage our experience in biopharmaceuticals and small molecules to develop, scale-up and optimize processes for ADCs in support of both clinical and commercial manufacturing processes.
service
Formulation Development
Our Drug Product Services team (Lonza DPS) offers a smart approach that considers the interplay between solubility, local tolerance and systemic toxicity for rapid and successful development of your parenteral small molecule program.
service
Analytical Services
We leverage our experience in biopharmaceuticals and small molecules to develop, robust analytical methods for the manufacture of intermediates and conjugated ADC drug substance. Phase appropriate methods are used to support both clinical and commercial m...
service
Targeting Agent and Carrier Protein
We have extensive experience in expressing, developing and manufacturing recombinant proteins for use as targeting agents or carrier proteins for bioconjugates. Let us simplify your supply chain by manufacturing all intermediates as well as your bioconju...
service
Drug Substance Manufacture
By leveraging our experience in biopharmaceuticals and small molecule drug process development and scale-up, we support manufacture of a variety of bioconjugates including high potency ADCs to support both clinical and commercial supply. We offer a varie...
service
Drug Product Manufacture
Our Drug Product Services team manufactures GMP liquid and lyophilized drug product batches for clinical and commercial supplies, as well as non-GMP batches for toxicological and, stability studies, in addition to reference standards. This encompases a v...
service
Process Definition and Sample Preparation
We have experience with a wide range of platform and novel bioconjugation technologies to support drug discovery activities. We can perform cell line construction/strain development, GMP cell banking, manufacture both your payload and linker and perform t...
service
Formulation Development
Our Drug Product Services team (Lonza DPS) offers a smart approach that considers the interplay between solubility, local tolerance and systemic toxicity for rapid and successful development of your parenteral small molecule program.
service
Analytical Services
We leverage our experience in biopharmaceuticals and small molecules to develop, robust analytical methods for the manufacture of intermediates and conjugated ADC drug substance. Phase appropriate methods are used to support both clinical and commercial m...
service
Targeting Agent and Carrier Protein
We have extensive experience in expressing, developing and manufacturing recombinant proteins for use as targeting agents or carrier proteins for bioconjugates. Let us simplify your supply chain by manufacturing all intermediates as well as your bioconju...
service
Drug Substance Manufacture
By leveraging our experience in biopharmaceuticals and small molecule drug process development and scale-up, we support manufacture of a variety of bioconjugates including high potency ADCs to support both clinical and commercial supply. We offer a varie...
service
Drug Product Manufacture
Our Drug Product Services team manufactures GMP liquid and lyophilized drug product batches for clinical and commercial supplies, as well as non-GMP batches for toxicological and, stability studies, in addition to reference standards. This encompases a v...
service
Process Definition and Sample Preparation
We have experience with a wide range of platform and novel bioconjugation technologies to support drug discovery activities. We can perform cell line construction/strain development, GMP cell banking, manufacture both your payload and linker and perform t...
service
Formulation Development
Our Drug Product Services team (Lonza DPS) offers a smart approach that considers the interplay between solubility, local tolerance and systemic toxicity for rapid and successful development of your parenteral small molecule program.
service
Analytical Services
We leverage our experience in biopharmaceuticals and small molecules to develop, robust analytical methods for the manufacture of intermediates and conjugated ADC drug substance. Phase appropriate methods are used to support both clinical and commercial m...
service
Targeting Agent and Carrier Protein
We have extensive experience in expressing, developing and manufacturing recombinant proteins for use as targeting agents or carrier proteins for bioconjugates. Let us simplify your supply chain by manufacturing all intermediates as well as your bioconju...
service
Drug Substance Manufacture
By leveraging our experience in biopharmaceuticals and small molecule drug process development and scale-up, we support manufacture of a variety of bioconjugates including high potency ADCs to support both clinical and commercial supply. We offer a varie...
service
Drug Product Manufacture
Our Drug Product Services team manufactures GMP liquid and lyophilized drug product batches for clinical and commercial supplies, as well as non-GMP batches for toxicological and, stability studies, in addition to reference standards. This encompases a v...
service
Process Definition and Sample Preparation
We have experience with a wide range of platform and novel bioconjugation technologies to support drug discovery activities. We can perform cell line construction/strain development, GMP cell banking, manufacture both your payload and linker and perform t...
service
Formulation Development
Our Drug Product Services team (Lonza DPS) offers a smart approach that considers the interplay between solubility, local tolerance and systemic toxicity for rapid and successful development of your parenteral small molecule program.
service
Analytical Services
We leverage our experience in biopharmaceuticals and small molecules to develop, robust analytical methods for the manufacture of intermediates and conjugated ADC drug substance. Phase appropriate methods are used to support both clinical and commercial m...
service
Targeting Agent and Carrier Protein
We have extensive experience in expressing, developing and manufacturing recombinant proteins for use as targeting agents or carrier proteins for bioconjugates. Let us simplify your supply chain by manufacturing all intermediates as well as your bioconju...
service
Drug Substance Manufacture
By leveraging our experience in biopharmaceuticals and small molecule drug process development and scale-up, we support manufacture of a variety of bioconjugates including high potency ADCs to support both clinical and commercial supply. We offer a varie...
service
Drug Product Manufacture
Our Drug Product Services team manufactures GMP liquid and lyophilized drug product batches for clinical and commercial supplies, as well as non-GMP batches for toxicological and, stability studies, in addition to reference standards. This encompases a v...
service
Formulation Development
Our Drug Product Services team (Lonza DPS) offers a smart approach that considers the interplay between solubility, local tolerance and systemic toxicity for rapid and successful development of your parenteral small molecule program.
service
Analytical Services
We leverage our experience in biopharmaceuticals and small molecules to develop, robust analytical methods for the manufacture of intermediates and conjugated ADC drug substance. Phase appropriate methods are used to support both clinical and commercial m...
service
Targeting Agent and Carrier Protein
We have extensive experience in expressing, developing and manufacturing recombinant proteins for use as targeting agents or carrier proteins for bioconjugates. Let us simplify your supply chain by manufacturing all intermediates as well as your bioconju...
service
Drug Substance Manufacture
By leveraging our experience in biopharmaceuticals and small molecule drug process development and scale-up, we support manufacture of a variety of bioconjugates including high potency ADCs to support both clinical and commercial supply. We offer a varie...
service
Drug Product Manufacture
Our Drug Product Services team manufactures GMP liquid and lyophilized drug product batches for clinical and commercial supplies, as well as non-GMP batches for toxicological and, stability studies, in addition to reference standards. This encompases a v...
service
Targeting Agent and Carrier Protein
We have extensive experience in expressing, developing and manufacturing recombinant proteins for use as targeting agents or carrier proteins for bioconjugates. Let us simplify your supply chain by manufacturing all intermediates as well as your bioconju...
service
Drug Product Manufacture
Our Drug Product Services team manufactures GMP liquid and lyophilized drug product batches for clinical and commercial supplies, as well as non-GMP batches for toxicological and, stability studies, in addition to reference standards. This encompases a v...

Bioconjugation (Visp, CH)

Drug product services (Basel, CH)


Related Content


Our GS Xceed® Gene Expression System has options to engineer and express conjugation-competent antibodies. Applications include antibody-drug conjugates (ADCs), half-life extension and imaging.

Unlike other contract development and manufacturing organizations (CDMOs), we are in the unique position to offer complete development and manufacturing services from both mammalian cell culture and advanced chemical synthesis for the production of Antibody-Drug Conjugates (ADCs). From process development to manufacturing scale-up, we are proud to offer more ways than ever to deliver your product.

technology
GS Xceed® Expression System
Our GS Xceed® Expression System is a robust, fully integrated, scalable mammalian expression platform for producing recombinant therapeutic proteins. Our extensive technical expertise and advanced manufacturing services provide the confidence you need to ...
technology
Chemical Synthesis Technologies
Lonza provides integrated chemical synthesis services for small molecules, from initial route scouting through to commercial-scale process intensification.
View recent articles on complex protein expression
View recent articles on complex protein expression
service
ADC Payload Product Development
Lonza offers tailored services to fit your specific ADC development plan. Learn about our expertise in antibodies, payloads, and bioconjugation.

Visp, Switzerland

Production, Research & Development, Sales & Support

Visp 3930
Switzerland